Coramsine

Coramsine is a cancer fighting compound composed of two agents that bind to a cancer cell’s receptors and rupture the cell membrane. It is currently undergoing extensive clinical trials as a treatment for various cancers including mesothelioma.

Coramsine is a registered trademark of Solbec Pharmaceuticals LTD.

What is Coramsine?

Coramsine is derived from Devil’s Apple (Solanum linnaeanum) a native Australian plant. The extract itself is composed of 2 agents, glycoalkaloids solasonine and solamargine that work together as active cancer fighters.

The mixture was originally called BEC and was available as a topical treatment for sunspots before it was acquired and studied as a possible cancer treatment.

How it works

The two cancer fighting agents destroy infected cells in a brand new technique. They bind to a cancer cell’s receptors located on the cell membrane and gain access into the cell disrupting cellular functions eventually causing it to burst.

The company coins this new approach to fighting cancer as “Oncotic Cell Death.”

Availability

The drug is currently in the middle stages of clinical trials and has yet to be approved by the FDA. It has shown incredible promise in studies:

The Mouse that Wouldn’t Die
A mouse was infected with mesothelioma and not only overcame it but developed resistance.

Solbec's website on this medication

About Us

Coramsine.org provides information about the cancer drug Cormasine.We are in no way affiliated or associated with Solbec Pharmaceuticals LTD.

Disclaimer

This site was not prepared by medical professionals. Consult a doctor for specific questions about treatment..